Patent: 8,277,822
✉ Email this page to a colleague
Summary for Patent: 8,277,822
| Title: | Botulinum toxin treatment |
| Abstract: | A liquid or semi-solid formulation of botulinum toxin for the preparation of a medicament intended to treat a disorder characterized by bladder spasms (e.g. urinary incontinence due to unstable bladder or unstable detrusor sphincter, voiding complications due to detrusor overactivity or unstable detrusor sphincter, urinary retention secondary to spastic sphincter or hypertrophied bladder neck and neurogenic bladder dysfunction secondary to Parkinson\'s disease, spinal cord injury, stroke or multiple sclerosis or characterized by a spasm reflex), wherein said medicament is for administration by infusion into the bladder or by other methods that do not involve injection into the bladder wall. |
| Inventor(s): | Dott; Chris (Berkshire, GB), Batchelor; John (Berkshire, GB), Bernard D\'Arbigny; Pierre (Courbevoie, FR), Cherif-Cheikh; Roland (Barcelona, ES) |
| Assignee: | Ipsen Biopharm Limited (Wrexham, GB) |
| Application Number: | 12/155,104 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,277,822
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2023-12-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
